CLAIM CARD
In the Q-SYMBIO sub-group analysis, CoQ10 supplementation demonstrated significant effects on several clinical endpoints. Mortensen 2019 reported statistically significant differences for multiple measures, including endpoints with P = 0.03, P = 0.03, and P < 0.001. These quantitative findings are detailed in Table 2 (Per-Study Endpoint Evidence).
Evidence grade: exploratory
Contradiction status: none
Publication: b8dee5f7-0023-4af5-bacc-446de915555a
Provenance: Derivation Web chain
Citation Support
source_1Xu 2024source_2Spiegeleer 2025source_3Shang 2024source_4Alehagen 2020source_5Phan 2020